GASTALDI, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 1.956
EU - Europa 1.046
AS - Asia 1.016
SA - Sud America 156
Continente sconosciuto - Info sul continente non disponibili 61
AF - Africa 60
OC - Oceania 2
Totale 4.297
Nazione #
US - Stati Uniti d'America 1.841
IT - Italia 365
SG - Singapore 333
CN - Cina 254
RU - Federazione Russa 128
DE - Germania 125
VN - Vietnam 124
BR - Brasile 114
IE - Irlanda 113
HK - Hong Kong 111
FI - Finlandia 69
GB - Regno Unito 66
FR - Francia 55
BD - Bangladesh 52
CA - Canada 48
IN - India 46
ZA - Sudafrica 31
ES - Italia 24
MX - Messico 21
JP - Giappone 18
NL - Olanda 17
SE - Svezia 15
AR - Argentina 13
PL - Polonia 13
BE - Belgio 12
CO - Colombia 11
MA - Marocco 10
AT - Austria 9
GP - Guadalupe 8
IL - Israele 8
IQ - Iraq 8
TR - Turchia 8
CZ - Repubblica Ceca 7
ID - Indonesia 7
GT - Guatemala 6
MY - Malesia 6
PK - Pakistan 6
EC - Ecuador 5
HN - Honduras 5
JM - Giamaica 5
LT - Lituania 5
NP - Nepal 5
SA - Arabia Saudita 5
BO - Bolivia 4
CW - ???statistics.table.value.countryCode.CW??? 4
GR - Grecia 4
KE - Kenya 4
PH - Filippine 4
SV - El Salvador 4
VE - Venezuela 4
CR - Costa Rica 3
ET - Etiopia 3
KG - Kirghizistan 3
NI - Nicaragua 3
PR - Porto Rico 3
PT - Portogallo 3
PY - Paraguay 3
SC - Seychelles 3
TH - Thailandia 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
CH - Svizzera 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EG - Egitto 2
JO - Giordania 2
TT - Trinidad e Tobago 2
UA - Ucraina 2
UZ - Uzbekistan 2
AG - Antigua e Barbuda 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CU - Cuba 1
DZ - Algeria 1
EE - Estonia 1
GD - Grenada 1
IR - Iran 1
IS - Islanda 1
KH - Cambogia 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
LY - Libia 1
MT - Malta 1
PA - Panama 1
PE - Perù 1
QA - Qatar 1
RO - Romania 1
SN - Senegal 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
Totale 4.240
Città #
San Jose 224
Council Bluffs 198
Singapore 198
Ashburn 192
Dublin 113
Chandler 110
Hong Kong 108
Dallas 99
Los Angeles 77
Munich 64
Beijing 55
New York 52
Ho Chi Minh City 50
Helsinki 47
Rome 46
Boardman 43
Milan 40
Lauterbourg 35
Buffalo 28
Hanoi 27
Johannesburg 27
Santa Clara 27
Pavia 22
Moscow 20
Redondo Beach 20
São Paulo 20
Turku 20
Orem 18
London 16
Montreal 16
Tokyo 16
Princeton 15
Wilmington 15
Brooklyn 14
Columbus 14
Lawrence 14
Shanghai 14
Cagliari 13
Nanjing 13
Atlanta 12
Chicago 12
Frankfurt am Main 12
Brussels 11
Denver 11
Florence 11
Medford 11
Stockholm 11
Mexico City 10
Naples 10
North Bergen 10
San Francisco 10
Ann Arbor 9
Bologna 9
Pune 9
Madrid 8
Manchester 8
Phoenix 8
Warsaw 8
Changsha 7
Chennai 7
Medellín 7
Nuremberg 7
Poplar 7
Toronto 7
Brno 6
Da Nang 6
Düsseldorf 6
Houston 6
Jacksonville 6
Montemale di Cuneo 6
Padua 6
Palermo 6
Rio de Janeiro 6
Seattle 6
Turin 6
Amsterdam 5
Baghdad 5
Boston 5
Calgary 5
Dhaka 5
Genoa 5
Guangzhou 5
Guatemala City 5
North Kansas City 5
Paris 5
Berlin 4
Cambridge 4
Casablanca 4
Falkenstein 4
Fortaleza 4
Hebei 4
Hyderabad 4
Nanchang 4
New Delhi 4
Querétaro 4
Shenyang 4
The Dalles 4
Venice 4
Athens 3
Bishkek 3
Totale 2.546
Nome #
Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment 186
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype 154
Conventional brain MRI features distinguishing limbic encephalitis from mesial temporal glioma 151
COVID-19 and Guillain–Barré Syndrome: A Case Report and Review of Literature 144
Predictors of outcome in a large retrospective cohort of patients with transverse myelitis 143
Diagnostics of anti-MAG antibody polyneuropathy 142
Clinical, prognostic and pathophysiological implications of MOG-IgG detection in the CSF: the importance of intrathecal MOG-IgG synthesis 141
Diagnostics of dysimmune peripheral neuropathies 137
Retrograde Amnesia in LGI1 and CASPR2 Limbic Encephalitis: Two Case Reports and a Systematic Literature Review 135
Seronegative autoimmune diseases: A challenging diagnosis 123
COVID-19 in patients with Myasthenia Gravis: epidemiology and disease course 123
Antibodies to neuronal surface antigens in patients with a clinical diagnosis of neurodegenerative disorder 120
Letter to Editor 111
Comparison of Fixed and Live Cell-Based Assay for the Detection of AChR and MuSK Antibodies in Myasthenia Gravis 110
MOG-IgG testing strategies in accordance with the 2023 MOGAD criteria: a clinical-laboratory assessment 110
Autoantibodies against neuroglial surface antigens: laboratory strategies for their detection and roles in acquired demyelinating syndromes, autoimmune encephalitis and acquired neuromyotonia 108
Conformational Antibodies to Proteolipid Protein-1 and Its Peripheral Isoform DM20 in Patients With CNS Autoimmune Demyelinating Disorders 106
Primary central nervous system lymphoma mimicking autoimmune encephalitis: the role of autoantibody testing 106
Clinical Course of Neurologic Adverse Events Associated With Immune Checkpoint Inhibitors 105
Lower motor neuron syndrome in a patient with HER2-positive metastatic breast cancer: A case report and review of the literature 104
AQP4 autoantibodies in patients with idiopathic normal pressure hydrocephalus 103
Beyond Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibodies: Alternative Causes of Optic Neuritis 101
Improving laboratory diagnostics in myasthenia gravis 100
General features, pathogenesis, and laboratory diagnostics of autoimmune encephalitis 94
Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD: a multicentre retrospective study 94
Visual System Involvement in Glial Fibrillary Acidic Protein Astrocytopathy 89
Movement disorders associated with neuronal antibodies: a data-driven approach 87
HaNDL syndrome: a reversible cerebral vasoconstriction triggered by an infection? A case report and a case-based review 85
Neurofilament-light chain quantification by Simoa and Ella in plasma from patients with dementia: a comparative study 80
Exposome, oxidative stress and inflammation in persons with multiple sclerosis: the EXPOSITION study protocol 70
Paraneoplastic Neurological Syndromes: Transitioning Between the Old and the New 69
Towards a standardised analysis of CSF in inflammatory neuropathies 69
COVID-19 and Guillain-Barré syndrome: A single-center prospective case series with a 1-year follow-up 66
Neurological complications due to copper deficiency in the context of Wilson disease treatment: a case report with long-term follow-up and review of the literature 65
LC-MS/MS-Based Determination of Ambroxol in Human Plasma and Cerebrospinal Fluid: Validation and Applicability in a Phase II Study on GBA-Associated Parkinson’s Disease Patients 61
Clustering of Exposome and Lifestyle Data to Support Differential Expression Analysis of Circulating miRNAs in Multiple Sclerosis 58
Insights from the EXPOSITION Study: Exposome-related microRNA Expression and Clinical Outcomes in People with multiple sclerosis 57
Unravelling the Acute, Chronic and Steroid-Refractory Management of High-Grade Neurological Immune-Related Adverse Events: A Call to Action 56
Adoptive JC Virus-Specific T Lymphocytes for the Treatment of Progressive Multifocal Leukoencephalopathy: Experience from Two Italian Centers 53
Applying the Supporting Features for MOGAD Diagnosis to Patients With Multiple Sclerosis 46
Biomarkers Identifying Tendency to Suicide (BITS): detection of biomarkers in adolescents with suicidal ideation or suicidal behavior for early prevention or intervention. A prospective cohort study 38
Two-year OCT follow-up in multiple sclerosis patients on Ofatumumab shows retinal preservation over non-antiCD20 treatments 35
Real-Life Evaluation of the MOGAD Diagnostic Criteria: Application Challenges and Discrepancies 31
The supporting role of Visual Evoked Potentials for the diagnosis of Optic Neuritis within the 2022 ICON criteria 29
Validation of the MOG-AR Score 27
Granulocyte and astrocyte markers distinguish MOG-antibody disease and neuromyelitis optica from multiple sclerosis 26
Diagnostic Value of the “Insular Knife‐Cut” Sign in Patients With Suspected Herpes Simplex Virus Encephalitis 20
Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study 18
Distinct patterns of small-fiber dysfunction in anti-myelin-associated glycoprotein-positive and negative paraproteinemic neuropathies 11
Totale 4.297
Categoria #
all - tutte 16.920
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.920


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202259 0 0 0 0 1 1 2 4 5 0 11 35
2022/2023310 26 25 5 33 26 27 0 12 133 7 14 2
2023/2024223 24 25 3 10 11 66 6 29 0 7 8 34
2024/2025732 44 40 35 20 18 52 38 16 179 47 75 168
2025/20262.014 119 88 151 258 241 105 277 87 211 131 260 86
2026/2027872 78 128 165 347 154 0 0 0 0 0 0 0
Totale 4.297